Caraco Pharmaceutical Laboratories Ltd. recalls Nimodipine Capsules 30 mg, Rx Only, For Institutional Use Only, a) 30-count unit dose Capsules (5x6 blister cards per ca
Recalled October 10, 2012 · FDA recall D-003-2013 · Caraco Pharmaceutical Laboratories
Hazard
Crystallization: Presence of crystals of Nimodipine within the capsule solution. · FDA Class II
Units
a) 2424 Cartons b) 2675 Cartons
Sold at
One direct account - Caraco Pharmaceutical Labroatories, LTD Detroit, Michigan 78 sub accounts
Description
Crystallization: Presence of crystals of Nimodipine within the capsule solution.
Product
Nimodipine Capsules 30 mg, Rx Only, For Institutional Use Only, a) 30-count unit dose Capsules (5x6 blister cards per carton), NDC 57664-135-64, b) 100-count unit dose Capsules (25x4 blister cards per carton), NDC 57664-135-65, Distributed by: Caraco Pharmaceutical Laboratories, Ltd. Detroit, MI 48202 Affiliate of Sun Pharmaceutical Industries, Inc.
Manufacturer(s)
Caraco Pharmaceutical Laboratories Ltd.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →